Entrada Therapeutics Inc. (TRDA)
NASDAQ: TRDA
· Real-Time Price · USD
5.29
0.04 (0.76%)
At close: Aug 15, 2025, 3:59 PM
5.27
-0.28%
After-hours: Aug 15, 2025, 04:10 PM EDT
Entrada Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 79.48M | 172.22M | 210.78M | 215.23M | 239.4M | 162.87M | 129.01M | 87.17M | 43.43M | 25.26M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1.1M | 900K | 1.83M | 2.57M | 3.37M | 3.17M | 2.78M | 2.57M | 2.27M | 2.07M | 1.52M | 1M | 500K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 76.48M | 169.43M | 207.06M | 211.76M | 236.03M | 159.7M | 126.24M | 84.6M | 41.16M | 23.19M | -1.52M | -1M | -500K | n/a | n/a | n/a | n/a | n/a |
Operating Income | -96.16M | 4.11M | 47.01M | 57.78M | 93.45M | 23.73M | 3.94M | -26.54M | -66.49M | -73.78M | -97.25M | -90.13M | -78.56M | -64.89M | -51.13M | -41.32M | -33.93M | -29.54M |
Interest Income | 15.34M | 19.7M | 19.47M | 18.64M | 16.92M | 16.77M | 15.22M | 11.88M | 8.62M | 4.81M | 2.63M | 1.68M | 883K | 489K | 22K | 22K | 22K | 13K |
Pretax Income | -76.91M | 23.81M | 66.48M | 76.42M | 110.38M | 40.51M | 12.06M | -21.77M | -64.97M | -76.07M | -94.62M | -88.43M | -77.73M | -64.45M | -51.16M | -41.38M | -33.94M | -29.47M |
Net Income | -73.35M | 24.78M | 65.63M | 54.95M | 104.44M | 23.48M | -6.68M | -19.34M | -78.34M | -74.79M | -88.83M | -85.06M | -75.95M | -63.48M | -51.15M | -41.38M | -33.94M | -29.47M |
Selling & General & Admin | 41.03M | 39.34M | 38.47M | 37.26M | 34.82M | 33.75M | 32.29M | 33.53M | 32.98M | 32.14M | 30.64M | 26.84M | 23.72M | 19.46M | 15.2M | 11.1M | 8.52M | 6.59M |
Research & Development | 133.62M | 126.88M | 122.48M | 117.62M | 108.56M | 103.72M | 99.15M | 87.28M | 84.05M | 73.99M | 66.61M | 63.29M | 54.84M | 45.42M | 35.93M | 30.22M | 25.41M | 22.95M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 174.65M | 166.22M | 160.94M | 154.88M | 143.37M | 137.47M | 131.44M | 120.81M | 117.02M | 106.14M | 97.25M | 90.13M | 78.56M | 64.89M | 51.13M | 41.32M | 33.93M | 29.54M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 950K | 950K | 950K | 950K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 126.84M | 168.11M | 163.77M | 157.45M | 145.94M | 139.14M | 132.18M | 120.81M | 117.02M | 106.14M | 97.25M | 90.13M | 78.56M | 64.89M | 51.13M | 41.32M | 33.93M | 29.54M |
Income Tax Expense | -3.55M | -972K | 859K | 21.47M | 5.93M | 17.02M | 18.74M | -2.42M | 13.38M | -1.28M | -5.79M | -3.38M | -1.78M | -973K | -13K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 41.34M | 41.07M | 40.84M | 40.63M | 34.18M | 33.5M | 33.37M | 33.28M | 33.16M | 32.37M | 31.35M | 31.3M | 31.28M | 31.25M | 20.78M | 28.31M | 20.48M | 20.48M |
Shares Outstanding (Diluted) | 41.34M | 41.07M | 43.05M | 40.63M | 35.51M | 34.79M | 33.37M | 34.78M | 33.16M | 32.37M | 31.35M | 31.3M | 31.28M | 31.25M | 20.78M | 28.31M | 20.48M | 20.48M |
EPS (Basic) | -1.78 | 0.87 | 1.99 | 1.67 | 3.09 | 0.70 | -0.21 | -0.63 | -2.45 | -2.39 | -2.84 | -3.02 | -2.78 | -2.54 | -2.29 | -1.82 | -1.65 | -6.35 |
EPS (Diluted) | -1.78 | 0.81 | 1.91 | 1.59 | 2.96 | 0.63 | -0.26 | -0.68 | -2.45 | -2.39 | -2.84 | -3.02 | -2.78 | -2.54 | -2.29 | -1.82 | -1.65 | -6.35 |
EBITDA | -94.23M | 6.05M | 48.94M | 59.45M | 95.12M | 26.13M | -1.16M | -31.85M | -71.28M | -78.83M | -95.35M | -88.4M | -77.04M | -63.58M | -50.01M | -40.47M | -33.29M | -29.08M |
EBIT | -92.24M | 8.47M | 55.59M | 70.66M | 110.38M | 36.29M | 5.18M | -29.59M | -73.59M | -80.88M | -97.25M | -90.13M | -78.56M | -64.89M | -51.13M | -41.32M | -33.93M | -29.54M |
Depreciation & Amortization | 1.94M | 2.84M | 2.83M | 2.57M | 3.37M | 3.17M | 2.78M | 2.57M | 2.27M | 2.03M | 1.88M | 1.72M | 1.52M | 1.31M | 1.12M | 851K | 639K | 456K |